Eddic Holdings (09860) plans to acquire 100% of the shares of Crown Bioscience International for 204 million US dollars.

Zhtng Cijng APP news, Edicon Holdings (09860) announced that on November 13, 2025 (after trading hours), the buyer Miramar Lifesciences Limited (a wholly-owned subsidiary of the company), the seller JSR Life Sciences, LLC, and the target company Crown Bioscience International entered into a share purchase agreement regarding the acquisition of 100% of the target company's issued shares. According to the share purchase agreement, the buyer conditionally agrees to purchase 100% of the target company's issued shares from the seller at the purchase price. Upon completion of the transaction, the target company will become a wholly-owned subsidiary of the buyer. The total purchase price for the acquisition is equivalent to 204 million US dollars.